MICHAEL EDWIN ERNST - pharmacy.uiowa.edu · 2008-present Work-without-compensation (WOC)...

MICHAEL EDWIN ERNST Clinical Professor

Department of Pharmacy Practice and Science, College of Pharmacy; Department of Family Medicine, Carver College of Medicine.

The University of Iowa, Iowa City, Iowa December, 2018

Contact Information : Michael E. Ernst, PharmD, BCPS, BCGP, FCCP, AHSCP-CHC The University of Iowa Dept of Family Medicine/01291-A PFP 200 Hawkins Dr Iowa City, IA 52242 Tel. 319/384-7756 Fax 319/384-7822 Email: [email protected] EDUCATIONAL AND PROFESSIONAL HISTORY Education 1991-1992 Luther College

Decorah, Iowa 1992-1997 Doctor of Pharmacy (with high distinction)

College of Pharmacy, The University of Iowa Iowa City, Iowa

1997-1998 Specialty Resident in Family Medicine College of Pharmacy, The University of Iowa

Iowa City, Iowa Preceptors: Michael W. Kelly, Pharm.D., M.S.; Teresa B. Klepser, Pharm.D.

Professional and Academic Positions Current Positions 2009-present Clinical Professor Department of Pharmacy Practice and Science


2008-present Work-without-compensation (WOC) appointment Veterans Affairs Medical Center Iowa City, Iowa 2005-present Secondary Appointment Department of Family Medicine Roy A. and Lucille J. Carver College of Medicine, The University of Iowa Iowa City, Iowa

mailto:[email protected]

Curriculum Vitae: Michael E. Ernst, Pharm.D., BCPS

2005-present Adjunct Clinical Pharmacy Specialist Department of Pharmaceutical Care University of Iowa Hospitals and Clinics Iowa City, Iowa 2001-present Founder, and Director, Ambulatory Blood Pressure Monitoring Consult Service. Family Care

Center, University of Iowa Hospitals and Clinics, Iowa City, Iowa. 1999-present Clinical Pharmacist – Anticoagulation Case Management Service Family Care Center, University of Iowa Hospitals and Clinics Iowa City, Iowa 1998-present Clinical Pharmacist – Multidisciplinary Geriatrics Assessment Clinic

Department of Family Medicine, The University of Iowa Iowa City, Iowa 1998-present Consultant Clinical Pharmacist – Mt. Vernon Family Practice/Iowa Health Physicians Mt. Vernon, Iowa 1997-present Clinical Pharmacist – Family Medicine Clinic Department of Family Medicine, The University of Iowa Iowa City, Iowa Past Positions 1992-1996 Pharmacist Intern - Fifth Avenue Pharmacy

Cedar Rapids, Iowa 1997-1998 Specialty Resident in Family Medicine College of Pharmacy/Department of Family Medicine, The University of Iowa, Iowa City, Iowa 1998-2004 Assistant Professor (Clinical) Division of Clinical and Administrative Pharmacy


2004-2009 Associate Professor (Clinical)

Division of Clinical and Administrative Pharmacy College of Pharmacy, The University of Iowa Iowa City, Iowa

Licensure and Certification Licensed Pharmacist, Iowa (1997-present) Iowa Center for Pharmaceutical Care (ICPC) training (1997) American Hypertension Specialist Certification Program- Certified Hypertension Clinician (AHSCP-CHC; formerly the ASH Specialist Program) (2016-2026)


Board Certified Pharmacotherapy Specialist (BCPS) Initial: 1998-2005 Recertification: 2005-2012, 2012-2019 Board Certified Geriatric Pharmacist (BCGP) (2017-2024) Recognition Honors, Awards, Outstanding Achievements 1991-1992 Larsen Presidential Scholarship, Luther College 1993-1994 Teeters/Wahl College of Pharmacy Scholarship 1994-1995 Iowa Pharmacy Foundation Scholarship 1995-1996 Wal-Mart Pharmacy Scholarship 1995-1997 University of Iowa College of Pharmacy Tuition Scholarship 1996 Pharmacy Opportunity Scholarship 1996 Perrigo Company Award for Excellence in Nonprescription Studies 1996 Rho Chi Society, Delta Chapter 1996-1997 Gordon H. Sheffield College of Pharmacy Scholarship 1997 Surgeon General’s Award for Excellence in Public Health Pharmacy Practice 1997 APhA/3M Partners for a Healthy Community Scholarship 1998 Iowa Pharmacists Association New Practitioner Leadership Conference participant 2001 1st Runner-up Best Poster, American College of Clinical Pharmacy (ACCP) Spring Practice and

Research Forum 2004 AACP-AFPE Pharmacy Faculty New Investigator Award 2006 Teacher of the Year, P2 Class, College of Pharmacy, The University of Iowa 2008 UIHC “Above and Beyond” Certificate of Appreciation 2008 Fellow, American College of Clinical Pharmacy 2009 Teacher of the Year, P2 Class, College of Pharmacy, The University of Iowa 2012 Ventures and Licensing Inventor Award (group award), University of Iowa Research Foundation 2016 2015 Hypertension top paper, Clinical Science [co-author] 2017 University of Iowa College of Pharmacy Faculty Preceptor of the Year 2018 Outstanding Reviewer - Pharmacotherapy TEACHING The University of Iowa Teaching Assignments Assigned Experiential Clerkships (By Academic Year) Current Preceptor, PHAR:9407 [formerly 046:181] Family Medicine Clerkship AY 2018-2019 14 students 2017-2018 13 students 2016-2017 13 students 2015-2016 14 students 2014-2015 14 students


2013-2014 14 students 2012-2013 14 students 2011-2012 14 students 2010-2011 14 students 2009-2010 14 students 2008-2009 14 students 2007-2008 14 students 2006-2007 14 students 2005-2006 16 students Preceptor, PHAR:8300 [formerly 046:003] Introductory Practice Experience 3 AY 2018-2019 4 students 2017-2018 4 students 2016-2017 4 students 2015-2016 4 students 2014-2015 4 students 2013-2014 2 students 2012-2013 4 students 2011-2012 4 students 2010-2011 3 students 2009-2010 4 students 2008-2009 2 students 2007-2008 4 students 2006-2007 4 students 2005-2006 1 students 2004-2005 4 students 2003-2004 3 students 2002-2003 4 students

Preceptor, Introductory Practice Experience 1 AY 2018-2019 2 students 2010-2011 2 students 2009-2010 1 student 2008-2009 1 student 2007-2008 6 students Preceptor, 046: 199 Family Practice Research Clerkship

AY 2011-2012 1 student 2009-2010 1 student

2000-2001 2 students

Preceptor, PHAR:9433 Academic Rotation AY 2016-2017 1 student Past Co-Preceptor, 046:179 Community Pharmaceutical Care Clerkship Co-Preceptor, 046:181 Family Practice Clerkship (with Dr. Michael Kelly) AY 2004-2005 28 students


2003-2004 36 students 2002-2003 36 students 2001-2002 43 students 2000-2001 39 students 1999-2000 37 students 1998-1999 25 students 1997-1998 25 students Student Work Supervised 2013-2016 ASPREE Study: Anne (Bergquist) Zepeski (2016 PharmD Candidate) Lecturer/Facilitator/Course-Coordination (Contact Hours By Semester)

Fall Semester 2018 PHAR:8252 IP: Musculoskeletal Course Coordinator (4.0 credit hr) PHAR:8252 IP: Musculoskeletal Gouty arthritis (1.5 hr) PHAR:8717 Seminars in Ambulatory Care Pharmacy Aspirin in Primary Prevention (2.0 hr) PHAR:8376 Professional Discovery: Presentation of Results project mentor (1.0 credit hr) Student team: Courtney Dawson, Alexa Klimek, Genan Alshawy, Amanda Toebe Spring Semester 2018

PHAR: 8261 IP: Neurology & Psychiatry Parkinson’s disease (2.0 hr) Other Movement Disorders (1.0 hr)

PHAR:8260 IP: Cardiovascular Hypertension (3.0 hr) Hypertension case discussion (3.0 hr)

PHAR:8140 Foundations of Pharmacy Practice II Overview of ADRs/DDIs (4.0 hr) Principles, Assessment, and Evaluation of Drug Therapy in Elders (4.0 hr)

PHAR:8379 APPE Preparation (1.0 credit hr) PHAR:8500 Advanced Drug Literature Evaluation and Application (2.0 credit hr, co-course coordinator)

PHAR:8255 Professional Discovery: Design, Methods and Data Collection project mentor (1.0 credit hr) Student team: Courtney Dawson, Alexa Klimek, Genan Alshawy, Amanda Toebe

MED:8411 Foundational Science and Drug Therapy (2.0 credit hr)

Fall Semester 2017 PHAR:8252 IP: Musculoskeletal Course Coordinator (4.0 credit hr) PHAR:8252 IP: Musculoskeletal


Gouty arthritis (1.5 hr) PHAR:8717 Seminars in Ambulatory Care Pharmacy SPRINT (2.0 hr) PHAR:8255 Professional Discovery: Design, Methods and Data Collection project mentor (1.0 credit hr) Student team: Courtney Dawson, Alexa Klimek, Genan Alshawy, Amanda Toebe Spring Semester 2017

PHAR:8342 Therapeutics: Neuropsychiatry Parkinson’s disease (2.0 hr) Other Movement Disorders (1.0 hr)

PHAR: 8261 IP: Neurology & Psychiatry Parkinson’s disease (2.0 hr) Other Movement Disorders (1.0 hr)

PHAR:8260 IP: Cardiovascular Hypertension (3.0 hr) Hypertension case discussion (3.0 hr)

PHAR:8140 Foundations of Pharmacy Practice II Overview of ADRs/DDIs (4.0 hr) Principles, Assessment, and Evaluation of Drug Therapy in Elders (4.0 hr)

Fall Semester 2016 PHAR:8252 IP: Musculoskeletal Course Coordinator (3.0 credit hr) PHAR:8252 IP: Musculoskeletal Gouty arthritis (1.0 hr) PHARA:8717 Seminars in Ambulatory Care Pharmacy Managing Hypertension in the Era of Shifting Guidelines (2.0 hr) Spring Semester 2016

PHAR:8342 Therapeutics: Neuropsychiatry Parkinson’s disease (2.0 hr) Other Movement Disorders (1.0 hr) PHAR:8204 Professional Practice Lab 4 (2.0 credit hr), class facilitator 1 class period (Blood Pressure Measurement Under Different Stressors)

PHAR:8243 Therapeutics: Cardiovascular Diseases Hypertension (4.0 hr)

PHAR:8201 Clinical Practice Skills I: Theory and Application Hypertension cases (2.0 hr)

PHAR:8140 Foundations of Pharmacy Practice II Overview of ADRs/DDIs (4.0 hr) ADR/DDI Lab activity (6.0 hr) Principles, Assessment, and Evaluation of Drug Therapy in Elders (4.0 hr)

Fall Semester 2015


PHAR:8240 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) PHAR:8240 Introduction to Therapeutics/Special Populations Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) PHARA:8717 Seminars in Ambulatory Care Pharmacy Managing Hypertension in the Era of Shifting Guidelines (2.0 hr) Spring Semester 2015

PHAR:8342 Therapeutics: Neuropsychiatry Parkinson’s disease (2.0 hr) Other Movement Disorders (1.0 hr) PHAR:8204 Professional Practice Lab 4 (2.0 credit hr), class facilitator 1 class period (Blood Pressure Measurement Under Different Stressors)

PHAR:8243 Therapeutics: Cardiovascular Diseases Hypertension (4.0 hr)

PHAR:8201 Clinical Practice Skills I: Theory and Application Hypertension case (2.0 hr)

Fall Semester 2014 PHAR:8240 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) PHAR:8240 Introduction to Therapeutics/Special Populations Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) PHARA:8717 Seminars in Ambulatory Care Pharmacy Hypertension Update (2.0 hr) Spring Semester 2014

046:164 Therapeutics: Neuropsychiatry Parkinson’s disease (2.0 hr) Other Movement Disorders (1.0 hr) 046:117 Professional Practice Lab 4 (2.0 credit hr), class facilitator 1 class period (Blood Pressure Measurement Under Different Stressors)

046:156 Therapeutics: Cardiovascular Diseases Hypertension (4.0 hr)

Fall Semester 2013 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr)


Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) 046:013 Seminars in Ambulatory Care Pharmacy Assessing Blood Pressure in the 21st Century (2.0 hr) Spring Semester 2013



Fall Semester 2012 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) 046:013 Seminars in Ambulatory Care Pharmacy Resistant Hypertension (2.0 hr) Spring Semester 2012



046:106 Clinical Practice Skills I Presenting a Journal Club (1.0 hr)

Fall Semester 2011 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) 046:013 Seminars in Ambulatory Care Pharmacy 6 Current Questions in Hypertension (2.0 hr) Spring Semester 2011




PEPPR Lecture – Maintaining Your Momentum: Next Steps in Professional Productivity After Your Residency Project

Fall Semester 2010 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Therapeutics Course Series Intro (0.5 hr) Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) 046:013 Seminars in Ambulatory Care Pharmacy Resistant Hypertension (2.0 hr)

046:101 Pharmacy Projects (3.0 credit hr) Student: Courtney Creary

Summer Semester 2010

050:170 Clinical Beginnings (College of Medicine), team facilitator Spring Semester 2010



Fall Semester 2009 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Therapeutics Course Series Intro (0.5 hr) Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr)

046:006 Dean’s Forum II “Primary Care Practice” (1.0 hr) 046:013 Seminars in Ambulatory Care Pharmacy


Resistant Hypertension (2.0 hr) Summer Semester 2009



046:108 Clinical Practice Skills III (2.0 credit hr), Case Facilitator (2 sessions) 046:156 Therapeutics: Cardiovascular Diseases

Hypertension (6.0 hr) Fall Semester 2008 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Therapeutics Course Series Intro (0.5 hr) Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) Spring Semester 2008


046:108 Clinical Practice Skills III (2.0 credit hr), Case Facilitator (3 sessions) 046:156 Therapeutics: Cardiovascular Diseases

Hypertension (6.0 hr) Fall Semester 2007 046:149 Introduction to Therapeutics/Special Populations, Course Coordinator (2.0 credit hr) 046:149 Introduction to Therapeutics/Special Populations Therapeutics Course Series Intro (0.5 hr) Preventive Health Care (2.0 hr) Overview of ADRs/Drug-Drug Interactions (2.0 hr) Applied Interpretation of Clinical Studies (1.0 hr) Geriatrics I (2.0 hr) Geriatrics II (2.0 hr) Osteoarthritis/Gout (2.0 hr) 046:159 Rheum/Immuno/Heme/Onc/Transplant Therapeutics Gout/SLE (2.0 hr)


Summer Semester 2007 046:101 Pharmacy Projects (3.0 credit hr) Student: Graziela Kalil



046:117 Professional Practice Lab 4 (2.0 credit hr), class facilitator 1 class period (Blood Pressure Measurement Under Different Stressors)

046:108 Clinical Practice Skills III (2.0 credit hr), Course Coordinator 046:164 Therapeutics: Neuropsychiatry Parkinson’s disease and Other Movement Disorders (2.0 hr) 046:006 Dean’s Forum II “MD/PharmD Interactions in Practice” (1.0 hr)

Fall Semester 2006

046:149 Introduction to Therapeutics/Special Populations Preventive Health Care (2.0 hr) Overview of Health Assessment (1.0 hr)

Overview of Common Laboratory Tests (4.0 hr) 046:158 Fluids, Electrolytes, Nutrition, GI and Renal Diseases Therapeutics

Viral Hepatitis: Alphabet Soup (2.0 hr) 046:101 Pharmacy Projects (2.0 credit hr) Student: Jessica Dobson

Spring Semester 2006

046:101 Pharmacy Projects (2.0 credit hr) Student: Heidi Wood 046:108 Clinical Practice Skills III (2.0 credit hr), Course Coordinator


046:106 Clinical Practice Skills I (2.0 credit hr), class facilitator 1 class period (Blood Pressure Measurement Under Different Stressors) 046:117 Professional Practice Lab 4 (2.0 credit hr), class facilitator 2 class periods

Fall Semester 2005 046:118 Professional Practice Lab 5 (2.0 credit hr), class facilitator 1 class period

046:149 Introduction to Therapeutics Preventive Health Care (2.0 hr) Overview of Health Assessment (1.0 hr)


Viral Hepatitis: Alphabet Soup (2.0 hr) 046:006 Dean’s Forum II “Primary Care” (1.0 hr)

Spring Semester 2005



046:106 Clinical Practice Skills I (2.0 credit hr), class facilitator 2 class periods 046:117 Professional Practice Lab 4 (2.0 credit hr), class facilitator 1 class period (Blood Pressure Measurement Under Different Stressors) 046:102 Honors Seminar

“Incorporating Research into Clinical Practice” (1.0 hr) Fall Semester 2004

046:118 Professional Practice Lab 5 (2.0 credit hr), class facilitator 1 class period

046:149 Introduction to Therapeutics Preventive Health Care (2.0 hr) Overview of Health Assessment (1.0 hr)


Viral Hepatitis: Alphabet Soup (2.0 hr) 046:108 Clinical Practice Skills III (2.0 credit hr), class facilitator 2 class periods

Spring Semester 2004 046:156 Therapeutics: Cardiovascular Diseases

Hypertension (5.0 hr) 096:224 Pharmacotherapeutics for Advanced Clinical Practice

Cardiovascular Therapeutics (6.0 hr) Rheumatology Agents (3.0 hr) 046:107 Clinical Practice Skills II (2.0 hr), class facilitator 2 class periods 046:101 Pharmacy Projects (2.0 hr) Student: Katherine Waack

Fall Semester 2003 046:149 Introduction to Therapeutics

Preventive Health Care (2.0 hr) Overview of Health Assessment (1.0 hr)

Overview of Common Laboratory Tests (4.0 hr) 046:107 Clinical Practice Skills III (2.0 hr), class facilitator 2 class periods

046:158 Fluids, Electrolytes, Nutrition, GI and Renal Diseases Therapeutics Drug-Induced Renal/Liver Disorders (2.0 hr)

046:106 Clinical Practice Skills I (1.0 credit hr), Course Coordinator 046:102 Honors Seminar Collaborative Practice Models (1.0 hr) Summer Semester 2003

117:110 Introduction to Clinical Skills (University of Iowa Physician Assistant Program) Practitioner Dispensing: Do’s and Don’ts Spring Semester 2003



096:224 Pharmacotherapeutics for Advanced Clinical Practice Cardiovascular Therapeutics (6.0 hr) Rheumatology Agents (3.0 hr) 046:107 Clinical Practice Skills II (2.0 hr), class facilitator 2 class periods 046:102 Honors Seminar Keeping Research Simple (1.0 hr)

Fall Semester 2002 046:125 Introduction to Pharmacotherapy and Health Care Preventive Health Care (2.0 hr)

Overview of Health Assessment (1.0 hr) Overview of Common Laboratory Tests (4.0 hr)

046:106 Clinical Practice Skills I (1.0 credit hr), Course Coordinator

Spring Semester 2002 046:139 Pharmacotherapy: Cardiovascular Diseases

Hypertension (6.0 hr) 096:224 Pharmacotherapeutics for Advanced Clinical Practice

Cardiovascular Therapeutics (6.0 hr) Rheumatology Agents (3.0 hr)

046:140 Pharmacotherapy: Fluids, Electrolytes, Nutrition, GI and Renal Diseases Drug-Induced Renal/Liver Disorders (2.5 hr)

046:195 Clinical Professional Skills Discussion Leader (2.0 hr) Fall Semester 2001

046:125 Introduction to Pharmacotherapy and Health Care Preventive Health Care (2.0 hr) Overview of Health Assessment (1.0 hr)

Overview of Common Laboratory Tests (4.0 hr) Spring Semester 2001

046:139 Pharmacotherapy: Cardiovascular Diseases Hypertension (5.0 hr)

096:224 Pharmacotherapeutics for Advanced Clinical Practice Cardiovascular Therapeutics (6.0 hr) Rheumatology Agents (3.0 hr)




Overview of Common Laboratory Tests (4.0 hr) Spring Semester 2000







Overview of Common Laboratory Tests (4.0 hr) 046:049 Introduction to Pharmaceutical Care, Problem-Based Learning (PBL) Facilitator (7.0

hr) Spring Semester 1999






Overview of Common Laboratory Tests (4.0 hr) 046:049 Introduction to Pharmaceutical Care, Problem-Based Learning (PBL) Facilitator (7.0

hr) Pharmacy Residents Trained 2006-present Adjunct Preceptor - Primary Care Residency (2 year), University of Iowa Hospitals and Clinics, Iowa City, IA (ASHP-accredited) 1998-2006 Primary Care Residency With Emphasis in Family Medicine, University of Iowa College of Pharmacy, Iowa City, IA (ASHP-accredited) Co-Preceptor (with Dr. Michael Kelly) 1998-1999 Gretchen Brown, Pharm.D. 1999-2000 Stephanie Hagan, Pharm.D. 2000-2001 Yvonne Desloover-Koch, Pharm.D. 2001-2002 Heidi S. Hilker, Pharm.D. 2002-2003 Shella R. Johnson, Pharm.D. 2003-2005 Jennifer J.G. Steffensmeier, Pharm.D.


Preceptor 2005-2006 Cynthia A. Weber, Pharm.D. 1999-present Adjunct Preceptor - Community Pharmaceutical Care Residency, CarePro Pharmacy, Mt. Vernon, IA (ASHP-accredited) Teaching (Other University of Iowa) 1997-present Department of Family Medicine, The University of Iowa. R1 Orientation Geriatrics Fellowship Family Medicine Grand Rounds Geriatric Staffing Primary Care Sports Medicine Fellowship Chronic Disease Management rotation (anticoagulation) Teaching (Other, non-University of Iowa) Graduate Student Supervision (external, 15%) 2015-present PhD Candidate: Jessica Lockery, MBBS School of Public Health and Preventive Medicine Monash University, Melbourne, Australia Anticipated thesis: August 2021 SCHOLARSHIP Peer-Reviewed Publications Original Research 1. Ernst ME, Klepser ME, Wolfe EJ, Pfaller MA. Antifungal dynamics of LY 303366, an investigational

echinocandin B analog, against Candida ssp. Diagn Microbiol Infect Dis 1996;26:125-31. 2. Ernst ME, Chalstrom CV, Currie JD, Sorofman B. Implementation of a community pharmacy-based influenza

vaccination program. J Am Pharm Assoc 1997;NS37:570-80. 3. Klepser ME, Wolfe EJ, Ernst ME, Pfaller MA. Growth medium effect on the antifungal activity of LY 303366.

Diagn Microbiol Infect Dis 1997;29:227-31. 4. Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill

curve results: proposal for standardized methods. Antimicrob Agents Chemother 1998;42:1207-12. 5. Klepser ME, Ernst EJ, Ernst ME, Messer SA, Pfaller MA. Evaluation of endpoints for antifungal susceptibility

determinations with LY 303366. Antimicrob Agents Chemother 1998;42:1387-91. 6. Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA. In vitro pharmacodynamic properties of MK-0991

determined by time-kill methods. Diagn Microbiol Infect Dis 1999;33:75-80. 7. Klepser TB, Doucette WR, Horton MR, Buys LM, Ernst ME, Ford JK, Hoehns JD, Kautzman HA, Logemann CD,

Swegle JM, Ritho M, Klepser ME. Assessment of patient perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000;20:83-7.

8. Ernst ME, Kelly MW, Hoehns JD, Swegle JM, Buys LM, Logemann CD, Ford JK, Kautzman HA, Sorofman BA, Pretorius RW. Prescription medication costs: a study of physician familiarity. Arch Fam Med 2000;9:1002-7.


9. Kelly MW, Swegle JM, Clarke C, Ernst ME. Appropriateness of medication use in Iowa Medicaid recipients in long-term care facilities receiving fifteen or more medications. Consult Pharm 2000;15:1184-91.

10. Ernst ME, Bergus GR, Sorofman BA. Patients’ acceptance of traditional and nontraditional immunization providers. J Am Pharm Assoc 2001;41:53-9.

11. Bergus GR, Ernst ME, Sorofman BA. The perceptions of family physicians about collaborative administration of routine immunizations. Prev Med 2001;32:255-61.

12. Ernst ME, Doucette WR, Dedhiya SD, Osterhaus MC, Kumbera PA, Osterhaus JT, Townsend RJ. Use of point-of-service health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy 2001;21:988-97.

13. Ernst ME, Brown GL, Klepser TB, Kelly MW. Medication discrepancies in an outpatient electronic medical record. Am J Health-Syst Pharm 2001;58:2072-5.

14. Osterhaus JT, Dedhiya SD, Ernst ME, Osterhaus M, Mehta SS, Townsend RJ. Health outcomes assessment in community pharmacy practices: a feasibility project. Arthritis Care Res 2002;47:124-31.

15. Ernst ME, Iyer SS, Doucette WR. Drug-related problems and quality-of-life in arthritis and low back pain sufferers. Value Health 2003;6:51-8.

16. Sinkovits HS, Kelly MW, Ernst ME. Medication administration in the daycare setting. J Am Pharm Assoc 2003;43:379-82.

17. Lund BC, Chrischilles EA, Carter BL, Ernst ME, Perry PJ. Development of a computer algorithm for defining an active drug list using an automated pharmacy database. J Clin Epidemiol 2003;56:802-6.

18. Ernst ME, Brandt K. Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office. J Am Pharm Assoc 2003;43:630-6.

19. Ernst ME, Bergus GR. Patient satisfaction with ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey. BMC Fam Pract 2003;4:15.

20. Zillich AJ, Carter BL, Ernst ME, Kelly MW. Effect of medication renewal access on blood pressure control. J Am Pharm Assoc 2003;43:561-5.

21. Hartz AJ, Bentler S, Noyes R, Hoehns J, Logemann C, Sinift S, Butani Y, Wang W, Brake K, Ernst M, Kautzman H. Randomized controlled trial of Siberian Ginseng for chronic fatigue. Psychol Med 2004;44:51-61.

22. Waack KE, Ernst ME, Graber MA. Informational content of official pharmaceutical company web sites about treatments for erectile dysfunction. Ann Pharmacother 2004;38:2029-34.

23. Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women’s quality of life is decreased by acute cystitis and antibiotic adverse events associated with treatment. Health Qual Life Outcomes 2005;3:45.

24. Steffensmeier JJG, Ernst ME, Kelly M, Hartz AJ. Do randomized controlled trials always trump case reports? A second look at propranolol and depression. Pharmacotherapy 2006;26:162-7.

25. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, Bergus GR. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-8.

26. VonMuenster S, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJG, Xu Y. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci 2008;30;128-35.

27. Bergus GR, Weber CA, Ernst ME, Ernst EJ. Do antibiotics improve the quality of life of patients with upper respiratory infections? It might depend on one’s luck. Int J Clin Pract 2008;62:855-9.

28. Ernst ME, Weber CA, Dawson JD, O’Connor MA, Lin W, Carter BL, Bergus GR. How well does a shortened time interval characterize results of a full ambulatory blood pressure monitoring session? J Clin Hypertens (Greenwich) 2008;10:431-5.

29. Fravel MA, Ernst ME, Weber CA, Dawson JD, Carter BL, Bergus GR. Influence of patient characteristics on success of ambulatory blood pressure monitoring. Pharmacotherapy 2008;28:1341-7.

30. Ernst ME, Shaw RF, Ernst EJ, Alexander B, Kaboli PJ. Atmospheric pressure changes and unexplained variability in INR measurements. Blood Coagul Fibrinolysis 2009;20:263-70.


31. Ernst ME, Carter BL, Zheng S, Grimm RH Jr. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens 2010;23:440-6.

32. Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010;170;1634-39.

33. Ernst ME, Lund BC. Renewed interest in chlorthalidone: evidence from the Veterans Health Administration. J Clin Hypertens (Greenwich) 2010;12:927-34.

34. Ernst ME, Sezate GS, Lin W, Weber CA, Dawson JD, Carter BL, Bergus GR. Indication-specific 6-hour systolic blood pressure thresholds can approximate 24-hour determination of blood pressure control. J Hum Hypertens 2011;25:250-55.

35. Ernst ME, Neaton JD, Grimm RH Jr, Collins G, Thomas W, Soliman EZ, Prineas RJ. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial. Hypertension 2011;58:1001-1007.

36. Staats MC, Ernst ME. Pharmacodynamic response to warfarin after conversion of atrial fibrillation or flutter to sinus rhythm. Am J Health-Syst Pharm 2012;69:1158-61.

37. Lund BC, Ernst ME. The comparative effectiveness of hydrochlorothiazide and chlorthalidone in an observational cohort of veterans. J Clin Hypertens (Greenwich) 2012;14:623-629.

38. Chen Z, Ernst ME, Ardery G, Xu Y, Carter BL. Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich) 2013;15:337-43.

39. Nelson MR, ASPREE Investigator Group. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials 2013;36:555-564.

40. Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension 2015;65:1041-1046.

41. Roush, GC, Ernst ME, Kostis J, Yeasmin S, Sica DA. Dose doubling, relative potency, and dose equivalence of potassium sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses. J Hypertens 2016;34:11-19.

42. Ernst ME, Davis BR, Soliman EZ, Prineas RJ, Okin PM, Ghosh A, Cushman WC, Einhorn PT, Oparil S, Grimm RH Jr; for the ALLHAT Collaborative Research Group. Electrocardiographic measures of left ventricular hypertrophy in the Antihhypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Am Soc Hypertens 2016;10:930-938.

43. Robman L, Guymer R, Woods R, Ward S, Wolfe R, Phung J, Hodgson L, Makeyeva G, Aung KZ, Gilbert T, Lockery J, Lepham Y, Storey E, Abhayaratna W, Reid D, Ernst ME, Nelson M, Reid C, McNeil J, on behalf of the ASPREE Investigator Group. Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: rationale and study design of the ASPREE-AMD study. Contemp Clin Trials Commun 2017;6:105-114.

44. McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, Storey E, Shah RC, Wolfe RS, Tonkin AM, Newman AB, Williamson JD, Lockery JE, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Trevaks RE, Orchard SG, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Grimm RH, on behalf of the ASPREE Investigator Group. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study. J Gerontol A Biol Sci Med Sci 2017;72:1586-1593.

45. Wolfe R, Murray AM, Woods RL, Kirpach B, Gilbertson D, Shah RC, Nelson MR, Reid CM, Ernst ME, Lockery J, Donnan GA, Williamson J, McNeil JJ. The ASPirin in Reducing Events in the Elderly (ASPREE) trial: statistical analysis plan. Int J Stroke 2018;13:335-338.

46. Roush GC, Abdelfattah R, Song S, Kostis JB, Ernst ME, Sica DA. Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta –analysis. J Hypertens 2018;36:1247-1255.

47. McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Ryan J, Radziszewska B, Grimm R, Murray AM, for the


ASPREE Investigator Group. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med 2018;379:1499-1508.

48. McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM, for the ASPREE Investigator Group. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med 2018;379:1509-1518.

49. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, Kirpach B, Shah RC, Ives DG, Storey E, Ryan J, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Radziszewska B, Grimm R, Murray AM, for the ASPREE Investigator Group. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med 2018;379:1519-1528.

50. Roush GC, Abdelfattah R, Song S, Ernst ME, Sica DA, Kostis JB. Hydrochlorothiazide versus chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: a systematic review and meta-analysis. J Clin Hypertens 2018;20:1507-1515.

51. Stocks N, Gonzalez-Chica DA, Woods RL, Lockery JE, Wolfe RSJ, Murray AM, Kirpach B, Shah RC, Nelson MR, Reid CM, Ernst ME, McNeil JJ, on behalf of the ASPREE Investigator Group. Baseline quality of life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study and their association with sociodemographic and modifiable lifestyle risk factors. Qual Life Res (epub ahead ofprint Nov 8, 2018)

Review 1. Ernst ME, Ernst EJ, Klepser ME. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?

Am J Health-Syst Pharm 1997;54:2569-84. 2. Ernst ME, Klepser ME, Fouts M, Marangos MN. Tetanus: pathophysiology and management. Ann

Pharmacother 1997;31:1507-13. 3. Ernst ME, Buys LM. Reevaluating the safety of concurrent warfarin and ibuprofen therapy: a case report. J

Pharm Technol 1997;13:244-7. 4. Ernst ME, Franey RJ. Acyclovir and ganciclovir induced neurotoxicity. Ann Pharmacother 1998;32:111-13. 5. Ernst ME, Kelly MW. Mibefradil, a pharmacologically distinct calcium antagonist. Pharmacotherapy

1998;18:463-85. 6. Ernst ME, Santee JA, Klepser TB. Oral corticosteroids for pain associated with herpes zoster. Ann

Pharmacother 1998;32:1099-1103. 7. Ernst ME, Ernst EJ. Effectively treating common infections in residents of long-term care facilities.

Pharmacotherapy 1999;19:1026-35. 8. Ernst ME, Graber MA. Methylxanthine use in anaphylaxis: what does the evidence tell us? Ann

Pharmacother 1999;33:1001-4. 9. Micek ST, Ernst ME. Tolcapone: a novel approach to Parkinson’s disease. Am J Health Syst Pharm

1999;56:2195-205. 10. Jepson TL, Ernst ME, Kelly MW. Current perspectives in the management of seasonal affective disorder. J

Am Pharm Assoc 1999;39:822-9. 11. Ernst ME. Toxicology & Clinical Pharmacology of Herbal Products. (Book Review). Fam Med 2000;32:651. 12. Ernst ME. Regular or super-aspirins? A review of thienopyridines or aspirin to prevent stroke. J Am Geriatr

Soc 2001;49:487-9. 13. Weimerskirch PR, Ernst ME. Newer dopamine agonists in the treatment of restless legs syndrome. Ann

Pharmacother 2001;35:627-30. 14. Maynard ML, Ernst ME. Leukotriene receptor antagonists in the treatment of allergic rhinitis. Ann

Pharmacother 2001;35:1274-7. 15. Koch YD, Ernst ME. Use of metformin in polycystic ovary syndrome. Ann Pharmacother 2001;35:1644-7.


16. Ernst ME, Bergus GR. Non-invasive, 24-hour ambulatory blood pressure monitoring: overview of technology and clinical applications. Pharmacotherapy 2002;22:597-612.

17. Ernst ME, Bergus GR. Ambulatory blood pressure monitoring. South Med J 2003;96:563-8. 18. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their

interchangeability. Hypertension 2004;43:4-9. 19. Koch YD, Ernst ME. Selective serotonin reuptake inhibitors for the treatment of hot flashes. Ann

Pharmacother 2004;38:1293-6. 20. Weber CA, Ernst ME. Antioxidants, supplements, and Parkinson’s disease. Ann Pharmacother 2006;40:935-

8. 21. Wood HM, Ernst ME. Renin-angiotensin system mediators and Raynaud’s phenomenon. Ann Pharmacother

2006;40:1998-2002. 22. Philbrick AM, Ernst ME. Amoxicillin-associated hemorrhagic colitis in the presence of Klebsiella oxytoca.

Pharmacotherapy 2007;27:1603-7. 23. Forsythe CT, Ernst ME. Do fluoroquinolones commonly cause arthropathy in children? Can J Emerg Med

2007;9:459-62. 24. Weber CA, Wood HM, Ernst ME. The effects of androstenedione supplementation on serum gonadal

hormones in men. J Pharm Technol 2007;23:349-55. 25. Trewet CB, Ernst ME. Resistant hypertension: identifying causes and optimizing treatment regimens. South

Med J 2008;101:166-73. 26. Ernst ME, Grimm RH Jr. Thiazide diuretics: 50 years and beyond. Curr Hypertens Rev 2008;4:256-65. 27. Philbrick AM, Ernst ME, McDanel DL, Ross MB, Moores KG. Metformin in renal dysfunction: is a serum

creatinine threshold appropriate? Am J Health Syst Pharm 2009;66:2017-23. 28. Ernst ME, Fravel MA. Febuxostat: a new and selective xanthine-oxidase/xanthine-dehydrogenase inhibitor.

Clin Ther 2009;31:2503-18. 29. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153-64. 30. Ernst ME, Gordon JA. Diuretic therapy: key aspects in hypertension and renal disease. J Nephrol

2010;23:487-93. 31. Fravel MA, Ernst ME. Management of gout in the older adult. Am J Geriatr Pharmacother 2011;9:271-285. 32. Ernst ME, Mann SJ. Diuretic use in hypertension. Semin Nephrol 2011;31:495-502. 33. Ernst ME. Ambulatory blood pressure measurements: recent evidence and clinical pharmacy applications.

Pharmacotherapy 2013;33:69-83. 34. Roush GC, Buddharaju V, Ernst ME. Is chlorthalidone better than hydrochlorothiazide in reducing

cardiovascular events in hypertensives? Curr Opin Cardiol 2013;28:426-432. 35. Roush GC, Buddharaju V, Ernst ME, Holford TR. Chlorthalidone: mechanisms of action and effect on

cardiovascular events. Curr Hypertens Rep 2013;15:514-521. 36. Roush GC, Kaur R, Ernst ME. Diuretics: a review and update. J Cardiovasc Pharmacol Ther 2014;19:5-13. 37. Roush GC, Ernst ME, Kostis JB, Kaur R, Sica DA. Not just chlorthalidone: evidence-based, diuretic

alternatives to hydrochlorothiazide for hypertension. Curr Hypertens Rep 2015 Apr; 17(4);540.doi:10.1007/s11906-015-0540-6.

38. Mann SJ, Ernst ME. Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention. Curr Hypertens Rep 2015 Apr;17(4):542.doi:10.1007/s11906-015-0542-4.

39. Schleich KT, Smoot MK, Ernst ME. Hypertension in athletes and active populations. Curr Hypertens Rep 2016;18:1-8.

40. Lovell AR, Ernst ME. Drug-induced hypertension: focus on mechanisms and management. Curr Hypertens Rep 2017;19:39. doi: 10.1007/s11906-017-0736-z.

Book Chapters


1. Ernst ME, Gottwald MD, Gidal BE. Parkinson’s disease. Chapter 53. In: Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK, Corelli RL, eds. Applied Therapeutics: The Clinical Use of Drugs. Philadelphia: Lippincott Williams & Wilkins. 8th ed. 2004.

2. Ernst ME, Steffensmeier JJG. Herbal and supplements formulary. Chapter 23. In: Graber MA, Jones JL, Wilbur JK, eds. The Family Medicine Handbook. Philadelphia: Elsevier. 5th ed. 2006.

3. Ernst ME. Parkinson’s disease. In: Dunsworth T, Richardson M, Cheng J, et al, eds. Pharmacotherapy Self-Assessment Program, 6th ed. Neurology and Psychiatry. Lenexa, KS: American College of Clinical Pharmacy, 2007:19-38.

4. Ernst ME, Clark EC, Hawkins DW. Gout and hyperuricemia. Chapter 96. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill. 7th ed. 2008.

5. Ernst ME, Gottwald MD. Parkinson’s disease and other movement disorders. Chapter 53. In Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK, Corelli RL, eds. Applied Therapeutics: The Clinical Use of Drugs. Philadelphia: Lippincott Williams and Wilkins. 9th ed. 2008.

6. Ernst ME, Clark EC. Gout. Chapter 36. In: Linn WD, Wofford MR, O’Keefe ME, Posey LM, eds. Pharmacotherapy in Primary Care. New York: McGraw-Hill. 1st ed. 2009.

7. Ernst ME. Hypertension. Chapter 21. In: Goode JV, Roman LM, Weitzel K, eds. Community Pharmacy Practice Case Studies. Washington, DC: American Pharmacists Association. 1st ed. 2009.

8. Carter BL, Ernst ME. Should diuretic therapy be first step therapy in all hypertensive patients? Chapter 2. In: Toth PP, Sica DA, eds. Clinical Challenges in Hypertension II. Oxford: Atlas Medical Publishing. 1st ed. 2010.

9. Ernst ME, Clark EC. Gout and hyperuricemia. Chapter 102. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill. 8th ed. 2011.

10. Ernst ME, Gottwald MD. Parkinson disease and other movement disorders. Chapter 57. In Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobsen P, Kradjan WA, Williams BR, eds. Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs. Philadelphia: Lippincott Williams and Wilkins. 10th ed. 2012.

11. Ernst ME. Diuretics. Chapter 4. In: Chatterjee K, Anderson M, Heistad D, Kerber RE, eds. Cardiology: An Illustrated Text Book. New Delhi: Jaypee Brothers Medical Publishers. 1st ed. 2012.

12. Ernst ME. Diuretics. In: Chatterjee K, Topol EJ, eds. Cardiac Drugs – An Evidence-Based Approach. New Delhi: Jaypee Brothers Medical Publishers. 1st ed. 2013.

13. Fravel MA, Ernst ME, Clark EC. Gout and hyperuricemia. Chapter 74. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill. 9th ed. 2014.

14. Ernst ME. Diuretics. In: Chatterjee K, Topol EJ, eds. Cardiac Drugs. New Delhi: Jaypee Brothers Medical Publishers. 2nd ed. 2015.

15. Fravel MA, Ernst ME. Gout and hyperuricemia. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill. 10th ed. 2017.

16. Carter BL, Ernst ME. Diuretics in hypertension. In: Bakris GL, ed. Hypertension. A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier. 3rd ed. 2017.

17. Ernst ME. Diuretics. Chapter 4. In: Chatterjee K, Anderson M, Heistad D, Kerber RE, eds. Cardiology: An Illustrated Text Book. New Delhi: Jaypee Brothers Medical Publishers. 2nd ed. [in press].

Books/Journals Edited 1. Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs. Alldredge BK, Corelli RL, Ernst ME,

Guglielmo BJ, Jacobsen PA, Kradjan WA, Williams BR, eds. Philadelphia: Lippincott Williams and Wilkins. 10th ed. 2012.


2. Section Editor - Antihypertensive Agents: Mechanisms of Drug Action section. Current Hypertension Reports, Volume 16, 2014.





7. Section Editor - Antihypertensive Agents: Mechanisms of Drug Action section. Current Hypertension Reports, Volume 21, 2019 (in preparation).

8. Editorial Board Member – Journal of the American College of Clinical Pharmacy (JACCP) 1/1/18-12/31/19. Monographs (print and web) 1. Ernst ME. Implementing a community pharmacy-based vaccination program. Educational unit for Career

Manager, published as part of APhA’s New Practitioner Initiative. 1997; February. 2. Ernst ME, Ernst EJ. Infections in long-term care facilities. Info-Connect, an educational pamphlet provided

by the Iowa Geriatric Education Center. January 2000. Updated 2009. 3. Ernst ME. Geriatrics assessment clinic. In: ACCP Ambulatory Care New Practitioner Survival

Guide/Resource Manual. Blake EW, Blair MM, eds. 1st edition. American College of Clinical Pharmacy, Ambulatory Care Practice and Research Forum. 2002. Page 103.

4. Carter BL, Dent LA, Ernst ME, et al. Community Pharmacy Resource Kit. American College of Clinical Pharmacy, Kansas City, MO. 2002. 54 pages.

5. Ernst ME, Carter BL. Update in the management of hypertension. Drugstore News 2003. Summer. [www.drugstorenews.com]

6. Ernst ME. Geriatrics assessment clinic. In: ACCP Ambulatory Care New Practitioner Survival Guide/Resource Manual. Blair MM, Klockars S, Wasik M, Askew J, Ishak A, Lindauer K, eds. 2nd edition. American College of Clinical Pharmacy, Ambulatory Care Practice and Research Forum. 2008. Page 164.

7. Ernst ME. Ambulatory blood pressure monitoring referral service. In: ACCP Ambulatory Care New Practitioner Survival Guide/Resource Manual. Blair MM, Klockars S, Wasik M, Askew J, Ishak A, Lindauer K, eds. 2nd edition. American College of Clinical Pharmacy, Ambulatory Care Practice and Research Forum. 2008. Page 94.

8. Haines ST, Hahn N, Ernst M, Saseen J. The ACCOMPLISH study – is one combination better than another? Capticast posted on IForumRx, June 15, 2011. Available at www.iforumrx.org

9. Ernst M. Drug-induced dysglycemia. DiabetesInsight Volume 2, Issue 19. Published online October 6, 2011. Available at www.audio-digest.org

10. Currie JD, Abrons JP, Seaba HH, Catney CM, Ernst ME. The University of Iowa teaching cases. American Pharmacy Association, 2012.

11. Ernst ME. Ambulatory blood pressure monitoring referral service. In: ACCP Ambulatory Care Pharmacist’s Survival Guide. Westberg SM, ed. 3rd edition. American College of Clinical Pharmacy, Ambulatory Care Practice and Research Forum. 2013. Page 18.

12. Ernst ME. Case Answer with Teaching Pearls to The University of Iowa Teaching Case #1807, Alzheimer’s dementia. The University of Iowa Teaching Cases [Internet]. Washington DC: American Pharmacists Association (US); 2013 July. Available from: http://pharmacylibrary.com/casestudies

http://www.iforumrx.org/

http://www.audio-digest.org/

http://pharmacylibrary.com/casestudies


13. Fravel MA, Ernst ME. Case Answer with Teaching Pearls to The University of Iowa Teaching Case #1019, Gout. The University of Iowa Teaching Cases [Internet]. Washington DC: American Pharmacists Association (US); 2013 July. Available from: http://pharmacylibrary.com/casestudies

14. Ernst ME, Fravel MA. Case Answer with Teaching Pearls to The University of Iowa Teaching Case #1328, Gout (complex). The University of Iowa Teaching Cases [Internet]. Washington DC: American Pharmacists Association (US); 2013 July. Available from: http://pharmacylibrary.com/casestudies

15. Fravel MA, Ernst ME. Hypertension Case Discussion. Active Learning Exercises [Internet]. Washington DC: American Pharmacists Association (US); 2014 April. Available from: http://pharmacylibrary.com/

16. Fravel MA, Ernst ME. Blood Pressure Measurement Under Varied Conditions. Active Learning Exercises [Internet]. Washington DC: American Pharmacists Association (US); 2014 March. Available from: http://pharmacylibrary.com/

17. Fravel MA, Ernst ME. Out-of-Office Blood Pressure Measurement. Active Learning Exercises [Internet]. Washington DC: American Pharmacists Association (US); 2014 April. Available from: http://pharmacylibrary.com/

Letters 1. Micek ST, Ernst ME. Tolcapone: More than meets the eye? Am J Health Syst Pharm 2000;57:1534. 2. Ernst ME, Hartz A. Phenylpropanolamine and hemorrhagic stroke. N Engl J Med 2001;344:1094. 3. Koch YD, Ernst ME, Kelly MW. Consumer perceptions about direct-to-consumer advertising and

prescription-to-non-prescription switch. Am J Health-Syst Pharm 2002;59:1568. 4. Johnson SR, Ernst ME, Graber MA. Commonly overlooked sources of vitamin K. Ann Pharmacother

2003;37:302. 5. Ernst ME, Moser M. Thiazide diuretics. N Engl J Med 2010;362:659-60. 6. Fravel MA, Ernst ME, Bergus GR. The psychological impact of ambulatory blood pressure monitoring. Am J

Health-Syst Pharm 2010;67:343-4. Invited Editorials and Commentaries 1. Ernst ME, Bergus GR. Ambulatory blood pressure monitoring: technology with a purpose. Am Fam

Physician 2003;67:2262-70. 2. Ernst ME. Ropinirole for the treatment of restless legs syndrome. CNS Drugs 2004;18:755. 3. Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH

trial into perspective. J Clin Hypertens (Greenwich) 2009;11:5-10. 4. Ernst ME. Nighttime blood pressure is the blood pressure. Pharmacotherapy 2009;29:3-6. 5. Carter BL, Ernst ME. Thiazide-induced hyperglycemia: can it be prevented? Am J Hypertens 2009;22:473. 6. Ernst ME. Resistant hypertension or resistant prescribing? Hypertension 2011;58:987-988. Scientific Abstracts and Poster/Platform Presentations Local/Regional 1. Ernst ME, Chalstrom CV, Currie JD, Sorofman B. “Establishing an influenza vaccination program in a

rural community pharmacy.” Iowa Pharmacists Association Annual Meeting. Davenport, Iowa. June 28, 1997. (Encore)

2. Brown GL, Klepser TB, Ernst ME, Kelly MW. “Pharmacist review to improve the accuracy of computerized medication profiles.” 25th Annual Midwest Pharmacy Residents Conference. St. Louis, Missouri. April 15-17, 1999.



http://pharmacylibrary.com/




3. Ernst ME, Kumbera PA, Osterhaus MC, Dedhiya SD. “Opportunities and challenges in community pharmacy-based research: experience with arthritis patients.” Iowa Pharmacy Association Annual Meeting. Cedar Rapids, Iowa. June 12, 1999.

4. Ernst ME, Dedhiya SD, Osterhaus JT. “Impact of drug therapy problems on the health status of ambulatory patients with musculoskeletal disorders.” Iowa Pharmacy Association Annual Meeting. Des Moines, Iowa. June 9-11, 2000. (Encore)

5. Ernst ME, Bergus GR, Sorofman BA. “Family physician and patient perceptions of traditional and non-traditional immunizers.” Iowa Pharmacy Association Annual Meeting. Des Moines, Iowa. June 9-11, 2000.

6. De Sloover Koch Y, Ernst ME, Klepser TB, Kelly MW. Consumer perceptions about direct-to-consumer advertising and Rx-OTC changes. 27th Annual Midwest Residents Pharmacy Conference. Houston, Texas. April 28, 2001.

7. Sinkovits H, Kelly MW, Ernst ME. Medication administration in daycares. Platform Presentation. 28th Annual Midwest Pharmacy Residents Conference. St. Paul/Minneapolis, MN. May 9-11, 2002.

8. Waack KE, Ernst ME, Graber MA. Informational content of pharmaceutical industry sponsored websites about treatments for erectile dysfunction. 5th Annual Research Achievement Symposium and Poster Session. College of Pharmacy, The University of Iowa. Iowa City, IA. April 27, 2004.

9. Steffensmeier J, Kelly M, Ernst M, Hartz A. Using the lowest level of medical evidence (case reports) to inform the highest (meta-analysis of RCTs). 30th Annual Midwest Pharmacy Residents Conference. Rochester, MN. May 6-8, 2004.

10. Farris KB, Phillips BB, Farley M, Ernst M, McDanel D, Steffensmeier J, Cavanaugh J. Predicting medication management capacity among older adults. 28th Annual Midwestern Conference on Health Care in the Elderly. Iowa City, IA. January 27, 2006. (Encore)

11. Weber CA, Ernst ME, Ernst EJ. Relationship between antibiotic use and quality of life in acute respiratory illnesses. 32nd Annual Midwest Pharmacy Residents Conference. Omaha, NE. April 27-29, 2006.

12. Weber CA, Ernst ME, Ernst EJ. Relationship between antibiotic use and quality of life in acute respiratory illnesses. 7th Annual Clinical and Administrative Pharmacy Research Day. College of Pharmacy, The University of Iowa. Iowa City, IA. April 26, 2006. (Encore)

13. O’Connor M, Ernst ME, Weber CA, Dawson JD, Carter BL, Bergus GR. Factors predicting a successful ambulatory blood pressure monitoring session. 8th Annual Clinical and Administrative Pharmacy Research Day. College of Pharmacy, The University of Iowa. Iowa City, IA. April 24, 2007.

14. O’Connor M, Ernst ME, Weber CA, Dawson JD, Carter BL, Bergus GR. Factors predicting a successful ambulatory blood pressure monitoring session. 33rd Annual Midwest Pharmacy Residents Conference. Omaha, NE. April 28-30, 2007.

15. O’Connor MA, Ernst ME, McDanel D, Bergus GR. The value of ambulatory blood pressure monitoring to patients. 9th Annual Clinical and Administrative Pharmacy Research Day. College of Pharmacy, The University of Iowa. Iowa City, IA. April 24, 2008.

16. Fravel MA, Ernst ME, McDanel D, Bergus GR. The value of ambulatory blood pressure monitoring to patients. 34th Annual Midwest Pharmacy Residents Conference. Omaha, NE. May 8-10, 2008.

17. Sezate G, Ernst M, Weber C, Carter B. Pharmacist-physician co-management of hypertension reduces blood pressure throughout 24-hours. University of Iowa Health Science Campus Research Week Poster Session. April 14, 2010.

18. Dawson C, Alshawy G, Klimek A, Toebe M, Schroeder M, Ernst ME. Self-reported health status and healthy behaviors of pharmacy students. Iowa Pharmacy Association Annual Meeting. Des Moines Marriott, Des Moines, Iowa. June 8-9, 2018.

National/International


1. Ernst ME, Chalstrom CV, Currie JD, Sorofman B. “Establishing an influenza vaccination program in a rural community pharmacy.” American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, Louisiana. December 8-12, 1996.

2. Ernst ME, Klepser ME, Wolfe EJ, Pfaller MA. “Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida spp.” American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, Louisiana. December 8-12, 1996.

3. Ernst EJ, Klepser ME, Messer SA, Ernst ME, Pfaller MA. “Antifungal dynamics of L743,872 against Candida spp. determined by time-kill methods.” 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada. September 28 - October 1, 1997. Abstract no. F-78.

4. Klepser ME, Ernst EJ, Ernst ME, Messer SA, Pfaller MA. “Evaluation of the endpoint for antifungal susceptibility determinations with LY 303366.” 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada. September 28 - October 1, 1997. Abstract no. F-71.

5. Klepser ME, Ernst EJ, Ernst ME, Lewis RE, Pfaller MA. “Antifungal time-kill curves, influence of test conditions on results.” 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada. September 28 - October 1, 1997. Abstract no. D-144.

6. Ernst ME, Kelly MW, Sorofman BA, Pretorius RW. “Familiarity of prescription medication costs among physicians in family medicine residency programs.” American College of Clinical Pharmacy (ACCP) Annual Meeting. Cincinnati, Ohio. November 8-11, 1998. Pharmacotherapy 1998;18:1144. Abstract no. 42.

7. Klepser TB, Doucette, WR, Horton MR, Buys LM, Ernst ME, Hoehns JD, Kautzman HA, Logemann CD, Swegle JM, Ritho M, Klepser ME. “Survey of herbal therapies usage and patients’ beliefs.” American College of Clinical Pharmacy (ACCP) Annual Meeting. Kansas City, Missouri. October 24-27, 1999. Pharmacotherapy 1999;19:1204. Abstract no. 75.

8. Ernst EJ, Adams D, Ernst ME, Klepser ME. “Serum enhances the in vitro activity of fluconazole against Candida albicans.” American College of Clinical Pharmacy (ACCP) Annual Meeting. Kansas City, Missouri. October 24-27, 1999. Pharmacotherapy 1999;19:1207. Abstract no. 92.

9. Osterhaus MC, Ernst ME, Kumbera PA, Dedhiya SD. “Measuring and using outcomes data for the management of arthritis patients in community based pharmacy settings.” American Pharmaceutical Association Annual Meeting. Washington, DC. March 10-14, 2000. J Am Pharm Assoc 2000;40:283-4. Abstract no. 47.

10. Ernst ME, Dedhiya SD, Osterhaus JT. “Impact of drug therapy problems on the health status of ambulatory patients with musculoskeletal disorders.” American College of Clinical Pharmacy (ACCP) Spring Practice and Research Forum. Monterey, CA. April 2-5, 2000. Pharmacotherapy 2000;20:354. Abstract no. 98.

11. DeSloover Koch YA, Ernst ME, Klepser TB, Kelly MW. Consumer perceptions about direct-to-consumer advertising and rx-otc changes. American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, Nevada. December 3-7, 2000.

12. Ernst ME, Doucette WR, Dedhiya SD, Osterhaus MC, Kumbera PA, Osterhaus JT, Townsend RJ. Utilization of health outcomes measures by community pharmacists to identify and resolve drug therapy problems in patients with musculoskeletal disorders. American College of Clinical Pharmacy (ACCP) Spring Practice and Research Forum. Salt Lake City, UT. April 22-25, 2001. Pharmacotherapy 2001;21:379. Abstract no. 76. 1st Runner-up Best Poster Category.

13. Bergus G, Ernst M, Sorofman B. Physician perceptions about administration of immunization outside of physician offices. Society of Teachers of Family Medicine (STFM) 34th Annual Spring Conference. Denver, CO. April 28-May 2, 2001. Fam Med 2001;33:542.

14. Dopp JM, Ernst ME, Dellsperger KC, Phillips BG. Comparison of amlodipine and felodipine on 24-hour ambulatory blood pressure in hypertensive patients. Sixteenth Annual American Society of


Hypertension Scientific Meeting and Exposition. San Francisco, CA. May 15-19, 2001. Am J Hypertens 2001;14:118A.

15. Ernst EJ, Ernst ME, Hoehns JD, Bergus, GA. Impact of resistance on the clinical outcomes in patients with acute uncomplicated cystitis. Presented at the Annual Meeting of the Society of Infectious Diseases Pharmacists, Chicago, Ill. Sept 21, 2001.

16. Egge JA, Ernst EJ, Ernst ME, Bergus GR. A retrospective analysis of resistance in community-acquired acute cystitis. 36th Annual ASHP Midyear Clinical Meeting, Dec 2-6, 2001, New Orleans, LA.

17. Zillich A, Carter BC, Ernst M, Kelly MW. Does a medication renewal service improve blood pressure control? American College of Clinical Pharmacy (ACCP) Spring Practice and Research Forum. Savannah, GA. April 7-10, 2002. Pharmacotherapy 2002;22:427. Abstract no. 145.

18. Zillich AJ, Barter BL, Ernst ME, Kelly MW. Effect of medication renewal access on blood pressure control. Seventeenth Annual American Society of Hypertension Scientific Meeting and Exposition. New York, NY. May 14-18, 2002. Am J Hypertens 2002;15:37A.

19. Bratten S, Shepley A, Currie JD, Brandt K, Ernst M, Farris KB, Jackson A, Clark R. Implementation of expanded pharmacist-provided care in a family practice clinic. American Pharmaceutical Association Annual Meeting and Exposition. Seattle, WA. March 26-30, 2004.

20. Farris KB, Phillips BB, Farley M, Ernst M, McDanel D, Steffensmeier J, Cavanaugh J. Predicting medication management capacity among older adults. American Pharmaceutical Association Annual Meeting and Exposition. Orlando, FL. April 1-4, 2005.

21. Bergus GR, Ernst EJ, Ernst ME, Hoehns JD. Measuring the effect of acute cystitis and antibiotic treatment. 27th Annual Meeting of the Society for Medical Decision Making. San Francisco, CA. October 21-24, 2005.

22. Currie JD, Seaba HH, Catney CM, Ernst ME. Development of a patient case database, ITeaCH, with on-line access as a resource for faculty. American Association of Colleges of Pharmacy Annual Meeting. San Diego, CA. July 8-12, 2006.

23. Bergus G, Weber C, Ernst M, Ernst E. Antibiotics do not improve quality of life of patients with nonspecific upper respiratory illnesses. 28th Annual Meeting of the Society for Medical Decision Making. Boston, MA. October 14-18, 2006.

24. Ernst ME, Swegle JM, Catney CM, Seaba HH, Currie JD. Integration of cases from the IowaTeach database into a clinical practice skills course. American College of Clinical Pharmacy (ACCP) Annual Meeting. St. Louis, MO. October 26-29, 2006 (Platform).

25. Bergus G, Weber C, Ernst M, Ernst E. Antibiotics do not improve quality of life of patients with nonspecific upper respiratory illnesses. American College of Clinical Pharmacy (ACCP) Annual Meeting. St. Louis, MO. October 26-29, 2006. (Encore)

26. Weber C, Ernst M, Dawson J, Bergus G, Carter B. Correlation of shortened ambulatory blood pressure monitoring sessions with full 24-hour sessions. American Society of Hypertension 22nd Annual Scientific Meeting and Exposition. Chicago, Ill. May 18-22, 2007. J Clin Hypertens 2007;9(suppl A):A87.

27. Von Muenster S, Carter B, Weber C, Ernst M, Milchak J, Steffensmeier J, Xu Y. Description of pharmacist interventions in the co-management of hypertension. American Society of Hypertension 22nd Annual Scientific Meeting and Exposition. Chicago, Ill. May 18-22, 2007. J Clin Hypertens 2007;9(suppl A):A209-10.

28. O’Connor M, Ernst ME, Weber CA, Dawson JD, Carter BL, Bergus GR. Factors predicting a successful ambulatory blood pressure monitoring session. American College of Clinical Pharmacy (ACCP) Annual Meeting. Denver, CO. October 14-17, 2007. (Encore)

29. Weber C, Ernst M, Dawson J, Bergus G, Carter B. Correlation of shortened ambulatory blood pressure monitoring sessions with full 24-hour sessions. American College of Clinical Pharmacy (ACCP) Annual Meeting. Denver, CO. October 14-17, 2007. (Encore)

30. O’Connor MA, Ernst ME, Weber CA, Dawson JD, McDanel DL, Carter BL, Bergus GR. Influence of patient characteristics on ambulatory blood pressure monitoring success. UHC Pharmacy Council Resident


Poster Session. Presented at the 42nd ASHP Annual Midyear Clinical Meeting. Las Vegas, NV. December 1, 2007.

31. Ernst ME, Lin W, Dawson JD, Carter BL, Bergus GR. What average 6-hr SBP optimally predicts 24-hr ABPM in the clinical setting? 23rd Annual Scientific Meeting and Exposition. New Orleans, LA. May 14-17, 2008. J Clin Hypertens 2008;10(suppl A):A68.

32. Ernst ME, Shaw RF, Ernst EJ, Alexander B, Kaboli PJ. Atmospheric pressure and INR variability: are they related? American College of Clinical Pharmacy (ACCP) Annual Meeting. Louisville, KY. October 19-22, 2008.

33. Sezate G, Ernst M, Weber C, Carter B. Pharmacist-physician co-management of hypertension reduces blood pressure throughout 24-hours. American College of Clinical Pharmacy (ACCP) Spring Practice and Research Forum. Charlotte, NC. April 23-27, 2010. Finalist, Best Student Poster Category.

34. Staats MC, Ernst ME. Impact of conversion to normal sinus rhythm on warfarin dose requirements. Presented at the 46th ASHP Annual Midyear Clinical Meeting. New Orleans, LA. December 4-8, 2011.

35. Lund BC, Ernst ME. The comparative effectiveness of chlorthalidone versus hydrochlorothiazide. VA HSR&D Meeting; National Harbor, MD. July 16, 2012.

36. Rahman A, Roush GC, Ernst ME, Kostis JB, Yeasmin S, Sica DA. Dose doubling, relative potency, and dose equivalence of potassium sparing diuretics affecting blood pressure and serum potassium. American Society of Hypertension, 2015 Annual Scientific Meeting and Exposition. New York Hilton Midtown, New York, NY. May 17, 2015.

37. Song S, Abdelfattah R, Kostis JB, Ernst ME, Sica DA, Roush GC. Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis. AHA Council on Hypertension/AHA Council on Kidney in Cardiovascular Disease/American Society of Hypertension Joint Scientific Sessions 2017. Hyatt Regency San Francisco. San Francisco, CA. September 14-17, 2017.

38. Robman LD, Guymer RH, Woods R, Hodgson L, Wolfe R, Phung J, Makeyeva G, LePham Y, Aung KZ, Gilbert T, Suleiman J, Maguire E, Lockery J, Trevaks R, Ernst M, McNeil J. The role of aspirin in age-related macular degeneration: the ASPREE-AMD randomized controlled trial. The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting. Hawaii Convention Center. Honolulu, HI. April 29-May 3, 2018.

39. Vos SS, Kooyman CD, Ernst ME, Kelly MW, Bergus GR, Bald EM, Bernard AM, Schroeder MC. Interprofessional education: an integration of pharmacy and medicine courses to create team-ready students. 2018 American Association of Colleges of Pharmacy (AACP) annual meeting. Boston, MA. July 21-25, 2018.

Presentations Invited Lectures/CME Presentations Local/Regional University of Iowa/Drake University Second Annual Pharmacy Student Leadership Conference speaker. University of Iowa Athletic Club, Iowa City, Iowa. September 1996. “Practical considerations for implementing a community pharmacy-based immunization program.” Immunization Certificate Program, sponsored by the Iowa Pharmacy Foundation and Iowa Center for Pharmaceutical Care. Collins Plaza Hotel, Cedar Rapids, Iowa. September 25-26, 1999. University of Iowa/Drake University Fifth Annual Pharmacy Student Leadership Conference speaker. City Plaza Hotel, Iowa City, Iowa. October 16, 1999.


“Practical considerations for implementing a community pharmacy-based immunization program.” Immunization Certificate Program, sponsored by the Iowa Pharmacy Foundation and Iowa Center for Pharmaceutical Care. Drake University, Des Moines, Iowa. November 20-21, 1999. “Interpretation of laboratory values.” Dubuque Area Pharmacists’ Association. Dubuque Diamond Jo Casino, Dubuque, Iowa. February 24, 2000. “Perceptions of immunization sources by individuals presenting to traditional or nontraditional immunization settings.” Iowa Pharmacy Foundation. Iowa Pharmacy Association headquarters, Des Moines, Iowa. April 25, 2000. “Practical considerations for implementing a community pharmacy-based immunization program.” Immunization Certificate Program, sponsored by the Iowa Pharmacy Foundation and Iowa Center for Pharmaceutical Care. Marriott Hotel, West Des Moines, Iowa. May 24, 2000. “Treating urinary tract infections in the elderly.” Iowa Pharmacy Association Educational Expo. University Park Holiday Inn, West Des Moines, Iowa. January 20, 2001. “Pharmacotherapy update in hypertension.” Iowa Physician Assistant Society Fall CME Conference. Collins Plaza Hotel and Convention Center, Cedar Rapids, Iowa. October 17, 2001. “Practitioner dispensing: do’s and don’ts.” University of Iowa Physician Assistant Program (117:110 Introduction to Clinical Skills). University of Iowa College of Medicine, Iowa City, Iowa. June 23, 2003. “Responding to patient demands for medications.” 2004 University of Iowa College of Nursing Spring Office Nurse CEU Conference. Sheraton Hotel, Iowa City, Iowa. March 31-April 1, 2004. “What will sustain you in your pharmacy future?” Rho Chi Keynote Speaker. The University of Iowa College of Pharmacy. Ramada Inn, Coralville, Iowa. April 2, 2004. “Responding to patient demands for medications.” Student Health Service medical staff educational conference. The University of Iowa Student Health Service. Westlawn building. August 11, 2004. “New pharmacology for dementia.” IOWA Geriatric Education Center Lecture Series. The University of Iowa. Hardin Library. August 18, 2004. “Interdisciplinary collaboration for elder care; resources for gerontology and gerontological nursing – panel discussion.” Best Nursing Practices in Care for Older Adults CE Program. University of Iowa Hospitals and Clinics Department of Nursing. East Room, 8RCP, UIHC. September 22, 2004. “What’s new in hypertension?” Iowa Nurse Practitioner Annual Conference. University Park Holiday Inn. West Des Moines, Iowa. October 21, 2004. “Avoiding common dangerous drug interactions.” Refresher Course for the Family Physician, sponsored by the Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa. Iowa Memorial Union. March 29, 2005. “Blood pressure considerations in the elderly.” IOWA Geriatric Education Center Lecture Series. The University of Iowa. Hardin Library. July 20, 2005.


“Is there a pill mom can take?” 28th Annual Midwestern Conference on Health Care in the Elderly. East Room, University of Iowa Hospitals and Clinics. January 27, 2006. “Hypertension: the importance of getting patients to their goal.” 2006 University of Iowa Homecoming Continuing Education Seminar. The University of Iowa College of Pharmacy. October 6, 2006. “Refractory hypertension.” IOWA Geriatric Education Center Lecture Series. The University of Iowa. Veterans Administration Medical Center. November 22, 2006. “Update on Parkinson’s disease practice parameters.” 2007 Iowa Pharmacy Association Educational Expo. Des Moines Marriott, Des Moines, Iowa. January 27, 2007. “Restless legs syndrome: a clinical update.” Log-In To Learn: An e-Journal Club for Pharmacists. The Collaborative Education Institute. College of Pharmacy, The University of Iowa, and the Iowa Pharmacy Association. March 14, 2007. “Atrial fibrillation: use of antiplatelets vs. warfarin therapy.” 2007 University of Iowa Homecoming Continuing Education Seminar. The University of Iowa College of Pharmacy. September 28, 2007. “Responding to patient demands for medications.” North Central College Health Association Annual Meeting. Sheraton Hotel and Conference Center, Iowa City, Iowa. October 19, 2007. “Hypertension Primer I.” Free Medical Clinic: Updates for Providers in Cedar Rapids and Iowa City. South Slope Community Center, North Liberty, Iowa. April 29, 2008. “All thiazide diuretics are NOT chlorthalidone.” Nephrology Grand Rounds, University of Iowa Hospitals and Clinics. September 3, 2008. “Controversies in automated drug alerts.” Pharmacy Society of Wisconsin 2008 Annual Meeting. Hotel Sierra, Green Bay, Wisconsin. September 12, 2008. “Lessons from ENHANCE.” 2007 University of Iowa Homecoming Continuing Education Seminar. The University of Iowa College of Pharmacy. September 26, 2008. “Hypertension Primer II.” Free Medical Clinic: Updates for Providers in Cedar Rapids and Iowa City. South Slope Community Center, North Liberty, Iowa. September 30, 2008. “Hypertension update, 2008.” IOWA Geriatric Education Center Lecture Series. The University of Iowa. Veterans Administration Medical Center. December 3, 2008. “Direct to consumer advertising in the older adult.” 31st Annual Midwestern Conference on Health Care in the Elderly. Sheraton Hotel, Iowa City, Iowa. January 30, 2009. “Controversies in automated drug alerts.” 2009 Alaska Pharmacy Association Annual Meeting. Marriott Hotel. Anchorage, Alaska. February 21, 2009. “It’s my first academic position – now what?” Panel discussion. 2009 University of Iowa Women’s Faculty Career Development Conference. Marriott Hotel. Coralville, Iowa. February 27, 2009.


“Resistant hypertension: identifying causes and optimizing treatment regimens.” University of Iowa Carver College of Medicine 2009 Progress in Internal Medicine conference. Marriott Hotel. Coralville, Iowa. October 9, 2009. “Resistant hypertension: identifying causes and optimizing treatment.” Current Topics in Primary Care CME series. University of Iowa Carver College of Medicine. Great River Medical Center. West Burlington, Iowa. March 5, 2010. “Resistant hypertension: identifying causes and optimizing treatment.” Current Topics in Primary Care CME series. University of Iowa Carver College of Medicine. Genesis Heart Institute. Davenport, Iowa. April 2, 2010. “New [and old] drug update.” 37th Annual Refresher Course for the Family Physician. Marriott Hotel and Conference Center. Coralville, Iowa. April 9, 2010. “Resistant hypertension: identifying causes and optimizing treatment.” Current Topics in Primary Care CME series. University of Iowa Carver College of Medicine. Grand River Center. Dubuque, Iowa. May 7, 2010. “Should blood pressure goals for diabetics be different than the general population?” 2010 University of Iowa Homecoming Continuing Education Seminar. Hotel Vetro, Iowa City, Iowa. October 1, 2010. “Management of hypertension in the elderly.” 33rd Annual Midwestern Conference on Health Care in the Elderly. Sheraton Hotel, Iowa City, Iowa. January 28, 2011. “Hydrochlorothiazide vs chlorthalidone: are there meaningful differences?” University of Iowa Division of Cardiology CE seminar series. University of Iowa Hospitals and Clinics. March 30, 2012. “Common and dangerous drug interactions.” 2012 University of Iowa College of Medicine Refresher Course for the Family Physician. Marriott Hotel and Conference Center, Coralville, Iowa. April 11, 2012. “Does 19th century technology still dominate your practice? Evaluating blood pressure in the 21st century.” Progress in Internal Medicine CME. University of Iowa Carver College of Medicine. Sheraton Hotel, Iowa City, Iowa. September 27, 2012. “Your Parkinson’s disease medications and you.” Iowa City area Parkinson’s Disease support group meeting. Mercy Hospital, Iowa City. February 19, 2013. “Does 19th century technology still dominate your practice? Evaluating blood pressure in the 21st century.” Current Topics in Primary Care – CME Series. University of Iowa Carver College of Medicine. Grand River Center. Dubuque, Iowa. May 17, 2013. “Should I prescribe an aspirin?” 36th Annual Midwestern Conference on Health Care in the Elderly. University Club. Iowa City, Iowa. January 24, 2014. “Research: what, why, how do I get involved?” University of Iowa Student chapter of ACCP. Zopf Auditorium, University of Iowa College of Pharmacy. Iowa City, Iowa. November 3, 2014. “Update on new drugs.” 2015 University of Iowa College of Medicine Refresher Course for the Family Physician. Marriott Hotel and Conference Center, Coralville, Iowa. April 14, 2015.


“Management of hypertension in the era of shifting guidelines.” Progress in Internal Medicine CME. University of Iowa Carver College of Medicine. Sheraton Hotel, Iowa City, Iowa. October 8, 2015. “Treating sleeplessness.” 38th Annual Midwestern Conference on Health Care in the Elderly. University Club. Iowa City, Iowa. January 22, 2016. “Hypertension: what’s your goal?” Midwest Pharmacy Expo. Holiday Inn & Convention Center. Des Moines, Iowa. February 16, 2018. “Treating hypertension in 2018: how low should you go?” 2018 Progress: Learning Together in the 21st Century. University of Iowa College of Pharmacy and University of Iowa Carver College of Medicine. Graduate Hotel, Iowa City, Iowa. October 18, 2018. National “Recent advances in the treatment of Parkinson’s disease.” American Pharmacists Association (APhA) 155th Annual Meeting and Exposition. Georgia World Congress Center. Atlanta, Georgia. March 18, 2007. “Comparison of diuretics in clinical practice.” 22nd Annual Scientific Meeting and Exposition, American Society of Hypertension (ASH). Hyatt Regency. Chicago, Illinois. May 20, 2007. “Rationale use of atypical combinations to achieve blood pressure goals.” Session co-chair, with Norman Kaplan, MD. 23rd Annual Scientific Meeting and Exposition, American Society of Hypertension (ASH). New Orleans Marriott. New Orleans, LA. May 15, 2008. “Putting it all together: comprehensive hypertension management.” 23rd Annual Scientific Meeting and Exposition, American Society of Hypertension (ASH). New Orleans Marriott. New Orleans, LA. May 16, 2008. “Hypertension as a silent prelude to heart failure.” Session co-chair, with John Bisognano, MD, PhD. 25th Annual Scientific Meeting and Exposition, American Society of Hypertension. New York Hilton. New York, NY. May 3, 2010. “Thiazide diuretic-induced hyperglycemia – etiology and impact on care.” Drug-Induced Dysglycemia session. 71st Scientific Sessions, American Diabetes Association. San Diego Convention Center, San Diego, CA. June 26, 2011. “Scientific Paper Platform Presentations, I.” Session chair. 2011 American College of Clinical Pharmacy Annual Meeting. David L. Lawrence Convention Center, Pittsburgh, PA. October 17, 2011. “Hypertension: getting blood pressure to goal.” Improving Clinical Outcomes and Patient Safety Through Interventions by Clinical Pharmacists session. Scientific Sessions 2011, American Heart Association. Orange County Convention Center, Orlando, FL. November 13, 2011. “Scientific Paper Platform Presentations, II.” Session chair. 2014 American College of Clinical Pharmacy Annual Meeting. Austin Convention Center, Austin, TX. October 14, 2014. “ECG-LVH in the ALLHAT study.” Presentation to the ALLHAT Steering Committee. ALLHAT Steering Committee teleconference. May 9, 2016.


Inservice and Departmental Presentations “New adverse drug reactions; toxicities of fen/phen therapy for obesity.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 11, 1997. “Weight-reduction management in the absence of fen/phen.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. September 25, 1997. “Highlights of JNC VI.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. November 13, 1997. “Update on new drugs: mibefradil.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. January 12, 1998. “New generation fluoroquinolones.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. January 15, 1998. “Blood pressure response to antihypertensive therapy in ambulatory patients.” Family Medicine Research Seminar. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. February 17, 1998. “Ambulatory blood pressure monitoring: clinical applications.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. March 2, 1998. “NSAID-induced gastroduodenal mucosal injury.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. April 30, 1998. “Update on new drugs: tolcapone.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 8, 1998. “Treatment guidelines for community-acquired pneumonia.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. July 2, 1998. “1998 guidelines for treatment of sexually transmitted diseases: focus on drug therapy.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. July 23, 1998. “Update on drugs in women’s health.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 10, 1998. “Tight glucose control in Type II diabetes: new data from the UK.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 5, 1998. “Role of corticosteroids in croup.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. October 7, 1998. “Rotaviral illness in children.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. November 23, 1998.


“Review of benign prostatic hyperplasia.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. November 25, 1998. “Selective COX-2 inhibition: celecoxib.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. January 14, 1999. “Update on 1999 immunizations: focus on LYMErix.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. February 25, 1999. “Drugs in the news recently.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 5, 1999. “Significant pharmacotherapy papers of 1999.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. April 15, 1999. “Guidelines for the management of chronic stable angina.” Family Medicine Pharmaceutical Forum. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 17, 1999. “Prevention and treatment of corticosteroid-induced osteoporosis.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. July 29, 1999. “New products for emergency contraception.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. September 2, 1999. “Update on influenza treatment.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. September 13, 1999. “Benchmarking health in community pharmacies: a demonstration project with arthritis patients.” Clinical and Administrative Pharmacy Division faculty seminar. Approved for continuing education credit (0.1 CEU), ACPE Universal Program Number 020-000-00-016-L04. College of Pharmacy, The University of Iowa, Iowa City, Iowa. March 8, 2000. “Hypertension in the elderly.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. March 13, 2000. “Update on ambulatory blood pressure monitoring.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. May 8, 2000. “Medical myths: sliding scale insulin – AKA making insulin work backwards.” Family Medicine Morning Report. Mercy Hospital. Iowa City, Iowa. May 11, 2000. “ACR 2000 update on the treatment of osteoarthritis.” Family Medicine Morning Report. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 5, 2000. “Newly approved (and disapproved) medications.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. December 4, 2000. “Prescription writing.” Family Medicine M3 Preceptorship Orientation. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. March 5, 2001.


“New cholesterol lowering guidelines.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 18, 2001. “Newly approved medications.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 1, 2001. “The Scoop on COX-2s.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. September 17, 2001. “Clinical experience with ambulatory blood pressure monitoring.” Clinical and Administrative Pharmacy Division faculty seminar. Approved for continuing education credit (0.1 CEU), ACPE Universal Program Number 020-000-01-031-L04. College of Pharmacy, The University of Iowa, Iowa City, Iowa. December 5, 2001. “Medical decision making in dementia therapy.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. December 19, 2001. “Controversies in cystitis management: focus on resistance.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. January 14, 2002. “Anticoagulation: back to basics.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 5, 2002. “Geriatric pharmacotherapy pearles.” R1 Geriatrics Orientation. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. September 26, 2002. “Recently approved meds.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 7, 2002. “New drugs, new indications.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 7, 2003. “Getting drugs from Canada.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 2, 2003. “Comparative effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressures.” Family Medicine Research Group Meeting. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 18, 2003. “Memantine.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. November 5, 2003. “Pharmacy update – ximelagatran.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. January 28, 2004. “Responding to patient demands for medications.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. March 31, 2004. “Update on drug safety: is the FDA failing to protect consumers?” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. December 1, 2004.


“Drug interaction primer.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. February 2, 2005. “Family practice case presentations.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. February 14, 2005. “New drugs of 2005.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 1, 2005. “Quality of life in patients with acute respiratory symptoms.” Family Medicine Research Group Meeting. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 1, 2005. “Family practice outpatient case presentations.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 13, 2005. “Incorporating research into clinical practice.” Medical Students Summer Research Seminar. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 19, 2005. “Prescribing smartly in geriatric outpatients.” Family Medicine R1 Geriatrics Orientation. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 21, 2005. “Pharmacy update.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 3, 2005. “Diuretics and beta blockers revisited.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. December 7, 2005. “Drug information question pot pourri.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. February 1, 2006. “New drugs/recent drug newsmakers.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 5, 2006. “Anticoagulation Primer.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 2, 2006. “The 7 principles for good practice in undergraduate education.” Family Medicine Faculty Development topic. The University of Iowa Department of Family Medicine faculty meeting. September 20, 2006. “Incorporating ambulatory blood pressure monitoring into your practice: when to order it and how to interpret the results.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 25, 2006. “Review of new drugs of 2006.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. January 3, 2007. “Restless legs syndrome.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 4, 2007.


“Drug therapy in geriatric patients.” R1 Geriatrics Orientation, Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 3, 2007. “Antithrombotics: anticoagulants and antiplatelets.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 31, 2007. “Are all thiazide-type diuretics created equal?” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. November 7, 2007. “Recent clinical trials update.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. May 2, 2008. “Geriatric pharmacotherapy.” R1 Geriatrics Orientation, Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 22, 2008. “Hemoglobin A1C: how low to go?” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 30, 2008. “All thiazide diuretics are NOT chlorthalidone.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 1, 2008. “Recent and significant pharmacotherapy papers.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 3, 2009. “Geriatric assessment clinic.” Family Medicine Grand Rounds (co-presenter). Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 3, 2009. “Diabetes Treatment FAQ.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. May 19, 2010. “Drug therapy in geriatric patients.” R1 Geriatrics Orientation, Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 29, 2010. “Resistant hypertension.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 18, 2010. “Medication use in the elderly.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 8, 2010. “Hypertension: something old, something new, and something in review.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. February 17, 2012. “Appropriate drug use in the elderly.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 11, 2012. “Performance-enhancing substances.” Family Medicine Sports Medicine Fellowship morning conference. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. May 2, 2012. “Geriatric pharmacy pearls.” R1 Geriatrics orientation. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 18, 2012.


“Analgesia in sports medicine.” Primary Care Sports Medicine Fellowship morning conference. University of Iowa Sports Medicine Center, The University of Iowa, Iowa City, Iowa. January 16, 2013. “Behaviorial weight management.” Family Medicine Grand Rounds. Co-presenter with Dr. Kate Jansen. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. March 8, 2013. “Primary and secondary prevention of cardiovascular disease.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 16, 2013. “Performance-enhancing substances update.” Primary Care Sports Medicine Fellowship morning conference. University of Iowa Sports Medicine Center, The University of Iowa, Iowa City, Iowa. January 22, 2014. “Hypertension: Rx pearls and measurement methods.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. February 2, 2015. “Geriatric pharmacotherapy.” Anesthesia Fellows morning conference. The University of Iowa, Iowa City, Iowa. February 18, 2015. “Geriatric pharmacotherapy.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. March 9, 2015. “NSAIDs.” Primary Care Sports Medicine Fellowship morning conference. Larson Conference room, Department of Orthopedics. The University of Iowa, Iowa City, Iowa. September 17, 2015. “Primary prevention of cardiovascular disease.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. June 13, 2016. “Medication use in the elderly.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 23, 2016. “Overview of study designs and interpretation.” UIHC Pharmacy Residents meeting. University of Iowa Hospitals and Clinics, Iowa City, Iowa. March 27, 2018. “What is hypertension? Panel.” Family Medicine Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. April 2, 2018. “Understanding descriptors of statistical and clinical significance.” UIHC Pharmacy Residents meeting. University of Iowa Hospitals and Clinics, Iowa City, Iowa. April 10, 2018. “Geriatric pharmacy pearls.” R1 Geriatrics Orientation. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. July 3, 2018. “Hypertension update.” Iowa Family Medicine Preceptorship Virtual Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. August 9, 2018. “Aspirin for primary prevention: latest evidence.” Iowa Family Medicine Preceptorship Virtual Grand Rounds. Department of Family Medicine, The University of Iowa, Iowa City, Iowa. October 11, 2018.


RESEARCH Funded Grants, Private

Title, Granting Agency, Year Funded, Principle Investigator Role on Project

Amount

1. Perceptions of patients about pharmacist administered immunizations. Iowa Pharmacy Association. 1998. M.E. Ernst.

$1,500.00

Principal Investigator. I conceived the study idea, designed the protocol with input from co-investigators, solicited funding, performed data collection, data analysis, presented poster presentation, and wrote and published the paper.

2. Perceptions of family physicians about pharmacist administered immunizations. Family

Health Foundation, Iowa Academy of Family Physicians. 1998. G.R. Bergus.

$1,800.00 Co Investigator. I assisted in conceiving the study idea and designing the protocol, and data collection. I helped edit the manuscript for publication.

3. Benchmarking health in community pharmacies: a demonstration project. G.D. Searle & Co. 1999. M. E. Ernst.

$137,000.00

Principal Investigator. I assisted in protocol development, project management, oversaw subject recruitment, data collection, data analysis and interpretation. I presented posters and authored publications from this project.

4. Glycemic control in medical inpatients receiving sliding scale insulin regimens versus routine diabetes medications. American Academy of Family Practice. 2000. L. Dickerson.

$24,000.00

($1,000 sub to UI) Primary investigator at the University of Iowa site. Responsible for subject enrollment. This study was a multi-center trial with the Medical University of South Carolina as the main study coordinating site.

Dickerson LM, Ye X, Sack JL, Hueston WJ. Glycemic control in medical inpatients with Type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial . Ann Fam Med 2003 1:29-35.

6. Documenting the value of a pharmacist-managed prescription renewal service. University of Iowa Health Care Pharmaceutical Enterprise, Value Analysis Program, Process Improvement Grant. 2000. M.W. Kelly; M.E. Ernst.

$27,700.00

Co-Principal Investigator. I assisted in identifying the research hypothesis and

protocol development. I assisted in data collection, analysis, and drafting of poster presentation, and wrote the manuscript for publication.

7. Impact of resistance on the clinical outcome in patients with acute uncomplicated

cystitis. Society of Infectious Diseases Pharmacists. 2000. E.J. Ernst.

$25,945.00


Co-Investigator. I assisted in identifying the research hypothesis and protocol development. I was responsible for subject enrollment and follow-up, and assisting in the interpretation of the data.

8. Establishment of a collaborative physician-pharmacist ambulatory blood pressure

monitoring clinic. University of Iowa Health Care Pharmaceutical Enterprise, Value Analysis Program, Process Improvement Grant. 2001. M.E. Ernst.

$9,195.00

Principal Investigator. I conceived the idea for development of the clinical service, wrote the grant to obtain money for capital equipment expenses, and implemented the clinical service.

10. Comparative effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressures. American Association of Colleges of Pharmacy, 2003-2005. M. E. Ernst

$10,000.00

Principal Investigator. I conceived the study idea, designed the protocol, obtained funding, and wrote the manuscript.

11. Evaluation of medication management capacity in the elderly. University of Iowa College of Pharmacy STIR Grant. 2003-2004. K.B. Farris; B.B. Phillips.

$10,000.00

Co-Investigator. I was responsible for subject enrollment and follow-up. 12. Development of a patient case database with on-line access as a resource for CAP

faculty. College of Pharmacy STIR Grant. 2004. J.D. Currie $20,600.00

Co-Investigator. I assisted in project design and implementation.

Funded Grants, Government

Title, Granting Agency, Year Funded, Principle Investigator Role on Project

Amount

1. Iowa Medicaid pharmaceutical case management program. Iowa Department of Human Services. Department of Health and Human Services, National Institutes of Health. 2000. E. Chrischilles.

$609,959.00

Consultant. Responsible for developing and delivering project training sessions to pharmacist participants.

2. Collaborative management of hypertension. National Institutes of Health, ZRG1 RPJB-2 Number 1 R01 HL69801-01A1. 2003-2006. B.L. Carter.

$1,948,095.00

Co-Investigator. 15% effort (year 1), 20% effort (year 2), 25% effort (year 3). Responsible for patient recruitment, training of 24-hour ambulatory blood pressure monitoring, and intervention of treatment subjects.

3. Enhanced continuity of pharmacy care for cardiovascular or pulmonary diseases. National Institutes of Health. R01 HL082711-01A2. 2007-2012. B.L. Carter.

$3,611,053.00

Case abstractor. 5% effort (year 2). Responsible for piloting case abstract development.


4. ASPirin in Reducing Events in the Elderly (ASPREE). National Institutes of Health. U01AG029824. 2010-2017. Subcontract to University of Iowa from Berman Center for Outcomes and Research. R. Grimm https://clinicaltrials.gov/ct2/show/NCT01038583

Est. $696,000.00 (UI sub)

University of Iowa PI. 12% (year 1), 8% (year 2), 5% (year 3-5), 20% (year 6), 5% (Year 7)

• Publications/Presentations/Ancillary Studies Committee member • US Operations Committee member • International Data Management Committee member • International Steering Committee Member (2016-present)

5. Expanding the medical home through mental health collaboration. Health Resources and Services Administration. HRSA-11-156 Residency Training in Primary Care Program. 2011-2016. G.R. Bergus.

$1,193,767.00

Clinical pharmacist. 2% effort (year 1 and 2)

6. The Glycemia Reduction Approaches in Diabetes Effectiveness (GRADE): A Comparative Effectiveness Study. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). 2013-2020. Subcontract to University of Iowa from George Washington University. W. Sivitz.

$2,095,678.00 yrs 1-5 (UI sub)

$1,039,139.00 yrs 6-8 (UI sub)

Co-investigator. 5% effort (year 1 and 2)

7. Treatment of Hypertension In Adults with ThiaZIDES: Pragmatic Trial Pilot Study. R34HL119790. 8/1/15-7/31/17. National Heart, Lung, and Blood Institute. K. Margolis. https://clinicaltrials.gov/show/NCT02591628

$672,618.00 (No direct funds to

Univ of Iowa) Project Consultant

PROFESSIONAL, GOVERNMENTAL, UNIVERSITY AND OTHER SERVICE Professional and Governmental Organizations Current Memberships American College of Clinical Pharmacy (ACCP) ACCP Ambulatory Care Practice and Research (PRN) Group ACCP Geriatric Practice and Research (PRN) Group Iowa Pharmacy Association (IPA) American Heart Association (via American Society of Hypertension - ASH) Appointed or Elected Committees/Offices/Boards 1998-1999 Iowa Pharmacists Association Professional Development and Education Committee 1998-1999 American College of Clinical Pharmacy Task Force on Compensation. Developed the ACCP

Program: How to Bill for Clinical Pharmacy Services. 1999-2000 American College of Clinical Pharmacy Credentials Committee 1999-2000 Elected member: Iowa Pharmacy Association House of Delegates 1999-2003 Board of Pharmaceutical Specialties (BPS) Specialty Council on Pharmacotherapy

1999 Cardiology Item Writing Panel 2000 Primary Care Item Writing Panel

https://clinicaltrials.gov/ct2/show/NCT01038583

https://clinicaltrials.gov/show/NCT02591628


2001-2003 Domain I Item Writing Panel 2000-2001 American College of Clinical Pharmacy Task Force on Clinical Pharmacy in the Community

Setting. Developed the ACCP Resource Kit on Community Pharmacy. 2001-2002 Elected member: Iowa Pharmacy Association House of Delegates 2003-2004 Elected member: Iowa Pharmacy Association House of Delegates 2007-2008 Elected member: Iowa Pharmacy Association House of Delegates 2007 American Society of Hypertension 2008 Annual Meeting Programming Committee 2007-08 American College of Clinical Pharmacy Research Affairs Committee 2008-09 Nominations Committee; American College of Clinical Pharmacy Ambulatory Care Practice and Research Network 2009 American Society of Hypertension 2010 Annual Meeting Programming Committee 2009-10 American College of Clinical Pharmacy, National Student Competition Item Writer’s Panel Committee 2010-12 Elected member: American Society of Hypertension Membership Committee 2013-15 Elected member: [Chair] American Society of Hypertension Membership Committee 2013-15 Elected: Research Institute Board of Trustees, American College of Clinical Pharmacy Chair, 2014 ACCP Annual Meeting Student Poster Judging Panel Secretary – Member Relations Committee 2015 2015-16 Chair - American College of Clinical Pharmacy Clinical Research Challenge Program Development Committee 2016-17 American College of Clinical Pharmacy Awards Committee 2017-present American College of Clinical Pharmacy Clinical Research Challenge Reviewer Panel 2018-19 Editorial Board Member (invited): Journal of the American College of Clinical Pharmacy (JACCP) 2018 ACCP Annual Meeting abstract co-chair 2018 ACCP Global Conference Best Student Poster judge 2018 ACCP Scholars Workshop for abstract improvement – Master Scholar Scientific Reviewer (at least 1 review/year)

1998 The Annals of Pharmacotherapy Journal of the American Pharmaceutical Association 1999

Pharmacotherapy Family Medicine

2000 Journal of the American Pharmaceutical Association

Pharmacotherapy Family Medicine Journal of the American Board of Family Practice 2001 Pharmacotherapy Family Medicine

Journal of Health Care for the Poor and Underserved


ACCP Spring Practice and Research Forum abstract reviewer ACCP Annual Meeting abstract reviewer

2002 Pharmacotherapy Family Medicine

Journal of the American Board of Family Practice Infections in Medicine ACCP Spring Practice and Research Forum abstract reviewer ACCP Annual Meeting abstract reviewer

2003 Pharmacotherapy

Journal of the American Board of Family Practice Journal of the American Pharmaceutical Association ACCP Spring Practice and Research Forum abstract reviewer ACCP Annual Meeting abstract reviewer Study Protocol Reviewer, University of Iowa General Clinical Research Center

2004 Pharmacotherapy Family Medicine Journal of the American Pharmaceutical Association The American Journal of Managed Care

ACCP Spring Practice and Research Forum abstract reviewer ACCP Annual Meeting abstract reviewer AACP New Investigators Program Panel Review Chair, Pharmacy Practice 2005 Journal of the American Board of Family Practice ACCP Annual Meeting abstract reviewer Pharmacotherapy Study Protocol Reviewer, University of Iowa General Clinical Research Center 2006 Journal of the American Pharmaceutical Association Mayo Clinic Proceedings Pharmacotherapy American Family Physician ACCP Spring Meeting abstract reviewer 2007 The Annals of Pharmacotherapy American Journal of Cardiovascular Drugs American Journal of Managed Care Journal of the American Pharmaceutical Association AACP New Investigators Program Reviewer Panel, Pharmacy Practice American Pharmacists Association Highlights Newsletter – June 2007 ACCP Annual Meeting abstract reviewer 2008 American Society of Hypertension Annual Meeting abstract reviewer


2008 Prescriber’s Letter Pharmacotherapy ACCP Annual Meeting abstract reviewer 2009 ACCP/ESCP International Congress abstract reviewer The Annals of Pharmacotherapy The Medical Letter

2009 Pharmacotherapy The Medical Letter Prescriber’s Letter Southern Medical Journal Expert Opinion on Pharmacotherapy American Journal of Hypertension ACCP Annual Meeting abstract reviewer

2010 American Society of Hypertension Annual Meeting abstract reviewer 2010 ACCP Spring Meeting abstract reviewer

2010 Pharmacotherapy Self-Assessment Program (PSAP-VII), Chronic Illnesses Book: Gout Prescriber’s Letter BMC Family Practice American Journal of Hypertension Pharmacotherapy Journal of Clinical Hypertension 2011 American Society of Hypertension Annual Meeting abstract reviewer 2011 Prescriber’s Letter (invited discussant, Seat at the Editorial Board Table-March, 2/16/11) Journal of Human Hypertension Journal of the American Society of Hypertension Pharmacotherapy American Journal of Hypertension Journal of Clinical Hypertension Journal of General Internal Medicine ACCP Annual Meeting abstract reviewer Hypertension

AACP New Investigators Program Reviewer Panel, Pharmacy Practice The Medical Letter 2012 American Society of Hypertension Annual Meeting abstract reviewer

2012 The Medical Letter Prescriber’s Letter Journal of the American Medical Association American Journal of Hypertension Journal of Clinical Hypertension iForum Rx


Journal of the American College of Cardiology Hypertension Research Hypertension Physicians’ Services Inc. Foundation (PSI) grant reviewer

2013 American Society of Hypertension Annual Meeting abstract reviewer 2013 Prescriber’s Letter Pharmacotherapy Journal of General Internal Medicine Journal of Clinical Hypertension American Journal of Hypertension ACCP Annual Meeting abstract reviewer Physicians’ Services Inc. Foundation (PSI) grant reviewer

2014 American Society of Hypertension Annual Meeting abstract reviewer 2014 Journal of Human Hypertension Prescriber’s Letter Hypertension Circulation Cochrane Renal Group: Diuretics for People with Chronic Kidney Disease (Protocol No. 318) Pharmacotherapy iForum Rx Journal of Clinical Hypertension Krames Stay Well Patient Education

2015 American Society of Hypertension Annual Meeting abstract reviewer Elsevier Publishing – AphA New Product Bulletin: Ivabradine

2015 Hypertension Prescriber’s Letter 2015 ACCP Global Conference on Clinical Pharmacy abstract reviewer Dutch Organisation for Health Research and Development (ZonMw) – grant reviewer Pharmacotherapy Journal of Clinical Hypertension Krames Stay Well Patient Education The New England Journal of Medicine Journal of the American Society of Hypertension American Journal of Hypertension 2016 American Society of Hypertension Annual Meeting abstract reviewer 2016 iForum Rx American Journal of Hypertension Dutch Organisation for Health Research and Development (ZonMw) – grant reviewer Journal of Clinical Hypertension Eisenberg Center for Clinical Decisions and Communications Science, Baylor College of Medicine Prescriber’s Letter Hypertension


2017 Journal of Clinical Hypertension The Medical Letter Prescriber’s Letter American Journal of Hypertension Circulation (Invited Guest Editor for: Circulation 2017;136:440-450) Pharmacotherapy 2017 AHA Council on Hypertension/ASH Joint Scientific Sessions abstract reviewer 2017 ACCP Annual Meeting abstract reviewer 2018 ACCP Updates in Therapeutics abstract reviewer American College of Clinical Pharmacy Clinical Research Challenge Reviewer Panel 2018 American College of Clinical Pharmacy Clinical Research Challenge Reviewer Panel American College of Clinical Pharmacy annual meeting abstract co-chair 2018 AHA Council on Hypertension/ASH Joint Scientific Sessions abstract reviewer Pharmacy Technician’s Letter Journal of Clinical Hypertension Swiss National Science Foundation – grant reviewer Journal of the American College of Clinical Pharmacy Clinical Journal of the American Society of Nephrology Hypertension Pharmacists’ Letter CE: Hypertension Department, College, and University Department of Pharmacy Practice and Science (formerly the Division of Clinical and Administrative Pharmacy) 1998-2002 Professional and Public Affairs Committee 2000 Ad Hoc Clinical Track Review Committee 2002-2007 Chair, Clinical Practice Skills Course Coordinators Committee

2003 Task Force on Clinical Track Patient Care Evaluation 2004-2011 Clinical Track Division Consulting Group (CT-DCG), Promotions and Tenure

2005-2009 Academic Committee Chair 2008-9

2007-2015 Pharmacotherapy Coordination Committee 2015-present Clinical Track Departmental Consulting Group (CT-DCG) chair (elected)

College of Pharmacy

2001-2002 Admissions Committee Member 2002-2003 Admissions Committee Member 2003-2004 Chair - Admissions Committee 2004-2005 Chair – Admissions Committee 2005-2006 Chair – Admissions Committee 2006-2007 Academic Performance Committee 2007 Fall 07 Homecoming CE Programming Advisory Committee 2007 Teacher-of-the-Year Award Committee 2007-2008 Admissions Committee Member 2008 Fall 08 Homecoming CE Programming Advisory Committee


2008-2009 ACPE Self-Study, Facilities and Resources Committee 2008-2011 Curriculum Committee Member 2010 Teacher-of-the-Year Award Committee 2011 Search Committee member – Chair of the Department of Pharmaceutical and

Experimental Therapeutics 2012-2015 Chair, Clinical Track Collegiate Consulting Group (CT-CCG), Promotions and Tenure

(elected) 2011-2014 Academic Performance/Awards and Recognition Committee 2013 Curriculum Transformer Group: Practice and PPL 2015-present Curriculum Committee Member (chair-2016-2018)

Department of Family Medicine 2004-present Department of Family Medicine Departmental Consulting Group 2013 Clinical Scholars Day judge 2014 Clinical Scholars Day judge 2017-present Geriatrics Fellowship Clinical Competency Committee University of Iowa Hospitals and Clinics 2000-2003 Ambulatory Care Medication Use Advisory Subcommittee 2005-present Anticoagulation Case Management Service Committee 2006-2014 Primary Care Pharmacy Residency Preceptors Committee University of Iowa 2014 Faculty Engagement Corps participant

MICHAEL EDWIN ERNST - pharmacy.uiowa.edu · 2008-present Work-without-compensation (WOC)...

Documents

Transcript of MICHAEL EDWIN ERNST - pharmacy.uiowa.edu · 2008-present Work-without-compensation (WOC)...